C-reactive protein and cerebral small-vessel disease: the Rotterdam Scan Study

E J van Dijk1, N D Prins, S E Vermeer

  • 1Department of Epidemiology and Biostatistics, Erasmus Medical Center, PO Box 1738, 3000DR Rotterdam, The Netherlands.

Circulation
|August 3, 2005
PubMed
Abstract

Insights

Higher C-reactive protein (CRP) levels are linked to the development and progression of white matter lesions in the brain, a key indicator of cerebral small-vessel disease. This suggests inflammation plays a role in this condition.

Area of Science:

  • Neurology
  • Cardiovascular Medicine
  • Immunology

Background:

  • Cerebral small-vessel disease, manifesting as white matter lesions and lacunar infarcts, is common in the elderly and linked to stroke and dementia risk.
  • The role of inflammatory processes in cerebral small-vessel disease remains unclear, unlike their established role in atherosclerosis.

Purpose of the Study:

  • To investigate the association between C-reactive protein (CRP) levels, a marker of inflammation, and the presence and progression of white matter lesions and lacunar infarcts.

Main Methods:

  • The study analyzed data from 1033 participants (aged 60-90) in the Rotterdam Scan Study, who underwent baseline and follow-up MRI scans.
  • Multivariate regression models were used to assess associations between CRP levels and markers of small-vessel disease, adjusting for cardiovascular risk factors and carotid atherosclerosis.

Main Results:

  • Elevated CRP levels were significantly associated with the presence and progression of white matter lesions, particularly marked progression.
  • Higher CRP levels also showed a tendency towards more prevalent and incident lacunar infarcts.

Conclusions:

  • Inflammatory processes, as indicated by CRP levels, may contribute to the pathogenesis of cerebral small-vessel disease.
  • Specifically, inflammation appears to play a role in the development of white matter lesions.